Avon Turnaround Strategies Wearing Well; Stock Gains 16% In Q2
This article was originally published in The Rose Sheet
Executive Summary
Avon's progress in implementing its turnaround initiatives, which has resulted in solid gains by the company's core U.S. beauty business, led the stock to a 15.7% advance to 46.28 in the second quarter.
You may also be interested in...
Avon Becoming Expected To Account For 10% Of Sales
Avon Becoming, the company's first retail initiative launching in Sears and J.C. Penney, is expected to generate 10% of sales, while Avon's traditional direct-sell business will account for 90%, Avon said.
Arden Gains Over 40% In Quarter As Firm Adds Class To Mass Distribution
Propelled by the early 2000 addition of a venerable name to its beauty products portfolio and a business more than doubled in size, Elizabeth Arden, formerly French Fragrances International, added 41% to its stock price in the first quarter.
Anew Retroactive Skin Cream Addresses Aging Through Cell Communication
Avon's Anew Retroactive age-reversing cream uses innovative technology to "attack aging at the cellular level," the company said at a press event in New York City June 6. Debuting in October, Retroactive is the "first skin care technology to attack aging where it starts," Avon maintains.